Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-05-19

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva's generic dexmethylphenidate hydrochloride under an original ANDA (ANDA 078908) for the treatment of attention-deficit/hyperactivity disor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride)

Snippet

ORIG AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)